MiR-122-5p promotes peritoneal fibrosis in a rat model of peritoneal dialysis by targeting Smad5 to activate Wnt/β-catenin pathway

References

• Kumar VA, Sidell MA, Jones JP, et al. Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system. Kidney Int. 2014;86(5):1016–1022.
   PubMed Web of Science ®Google Scholar
• Jain AK, Blake P, Cordy P, et al. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol. 2012;23(3):533–544.
   PubMed Web of Science ®Google Scholar
• Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13(2):470–479.
   PubMed Web of Science ®Google Scholar
• Aroeira LS, Aguilera A, Sánchez-Tomero JA, et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol. 2007;18(7):2004–2013.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang L, Xu L, et al. Targeting src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition. Oncotarget. 2017;8(48):83872–83889.
   PubMedGoogle Scholar
• Morishita Y, Ookawara S, Hirahara I, et al. HIF-1α mediates hypoxia-induced epithelial-mesenchymal transition in peritoneal mesothelial cells. Ren Fail. 2016;38(2):282–289.
   PubMed Web of Science ®Google Scholar
• Yao L, Ye Y, Mao H, et al. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson’s disease. J Neuroinflammation. 2018;15(1):13.
   PubMedGoogle Scholar
• Hu J, Shan Z, Hu K, et al. Feng Y: miRNA-223 inhibits epithelial-mesenchymal transition in gastric carcinoma cells via Sp1. Int J Oncol. 2016;49(1):325–335.
   PubMed Web of Science ®Google Scholar
• Jaca A, Govender P, Locketz M, et al. The role of miRNA-21 and epithelial mesenchymal transition (EMT) process in colorectal cancer. J Clin Pathol. 2017;70(4):331–356.
   PubMed Web of Science ®Google Scholar
• Domingues C, Serambeque BP, Laranjo Cândido MS, et al. Epithelial-mesenchymal transition and microRNAs: challenges and future perspectives in oral cancer. Head Neck. 2018;40(10):2304–2313.
   PubMed Web of Science ®Google Scholar
• Morishita Y, Yoshizawa H, Watanabe M, et al. MicroRNA expression profiling in peritoneal fibrosis. Trans Res. 2016;169:47–66.
   Google Scholar
• Lin F, Wu X, Zhang H, et al. A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis. BMC Nephrol. 2015;16:48.
   PubMed Web of Science ®Google Scholar
• Li X, Liu H, Sun L, et al. MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor. J Cell Mol Med. 2019;23(4):2372–2383.
   PubMed Web of Science ®Google Scholar
• Szeto CC, Chow KM, Kwan BC, et al. Peritoneal dialysis effluent miR-21 and miR-589 levels correlate with longitudinal change in peritoneal transport characteristics. Clin Chim Acta. 2017;464:106–112.
   PubMed Web of Science ®Google Scholar
• Duan Y, Dong Y, Dang R, et al. MiR-122 inhibits epithelial mesenchymal transition by regulating P4HA1 in ovarian cancer cells. Cell Biol Int. 2018;42(11):1564–1574.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang X. miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling. J Cell Physiol. 2020;235(3):2825–2835.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Bajo MA, Del Peso G, et al. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int. 2016;90(3):515–524.
   PubMed Web of Science ®Google Scholar
• Krediet RT. Ultrafiltration failure is a reflection of peritoneal alterations in patients treated with peritoneal dialysis. Front Physiol. 2018;9:1815.
   PubMed Web of Science ®Google Scholar
• Yanai K, Ishii H, Aomatsu A, et al. MicroRNAs in peritoneal fibrosis: a systematic review. Discov Med. 2018;26(145):271–280.
   PubMed Web of Science ®Google Scholar
• Calvopina DA, Chatfield MD, Weis A, et al. MicroRNA sequencing identifies a serum MicroRNA panel, which combined with aspartate aminotransferase to platelet ratio index can detect and monitor liver disease in pediatric cystic fibrosis. Hepatology. 2018;68(6):2301–2316.
   PubMed Web of Science ®Google Scholar
• Kim KK, Sheppard D, Chapman HA. TGF-β1 signaling and tissue fibrosis. Cold Spring Harb Perspect Biol. 2018;10(4):a022293.
   PubMed Web of Science ®Google Scholar
• Lepistö J, Peltonen J, Vähä-Kreula M, et al. Platelet-derived growth factor isoforms PDGF-AA, -AB and -BB exert specific effects on collagen gene expression and mitotic activity of cultured human wound fibroblasts. Biochem Biophys Res Commun. 1995;209(2):393–399.
   PubMed Web of Science ®Google Scholar
• Shin HS, Ko J. Metformin ameliorates the phenotype transition of peritoneal mesothelial cells and peritoneal fibrosis via a modulation of oxidative stress. Sci Rep. 2017;7(1):5690.
   PubMedGoogle Scholar
• Ji S, Deng H, Jin W, et al. Beta-catenin participates in dialysate-induced peritoneal fibrosis via enhanced peritoneal cell epithelial-to-mesenchymal transition. FEBS Open Bio. 2017;7(2):265–273.
   PubMed Web of Science ®Google Scholar
• Sung SA, Kim DH, Oh KH, et al. The role of cathepsin B in peritoneal fibrosis due to peritoneal dialysis. Int J Nephrol. 2019;2019:4150656.
   PubMed Web of Science ®Google Scholar
• Yang AH, Chen JY, Lin JK. Myofibroblastic conversion of mesothelial cells. Kidney Int. 2003;63(4):1530–1539.
   PubMed Web of Science ®Google Scholar
• Wang CY, Xiao X, Bayer A, et al. Ablation of hepatocyte Smad1, Smad5, and Smad8 causes severe tissue iron loading and liver fibrosis in mice. Hepatology. 2019;70(6):1986–2002.
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Sreekumar PG, Spee C, et al. αB-Crystallin regulates subretinal fibrosis by modulation of Epithelial-Mesenchymal transition. Am J Pathol. 2016;186(4):859–873.
   PubMed Web of Science ®Google Scholar
• MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17(1):9–26.
   PubMed Web of Science ®Google Scholar
• Steinhart Z, Angers S. Wnt signaling in development and tissue homeostasis. 2018;145(11):dev146589.
   Google Scholar
• Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012;149(6):1192–1205.
   PubMed Web of Science ®Google Scholar
• Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127(3):469–480.
   PubMed Web of Science ®Google Scholar
• Guo Y, Xiao L, Sun L, et al. Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res. 2012;61(4):337–346.
   PubMed Web of Science ®Google Scholar
• Surendran K, Schiavi S, Hruska KA. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol. 2005;16(8):2373–2384.
   PubMed Web of Science ®Google Scholar
• Guo Y, Sun L, Xiao L, et al. Aberrant wnt/Beta-Catenin pathway activation in Dialysate-Induced peritoneal fibrosis. Front Pharmacol. 2017;8:774.
   PubMed Web of Science ®Google Scholar
• Yu M, Shi J, Sheng M, et al. Astragalus inhibits epithelial-to-Mesenchymal transition of peritoneal mesothelial cells by down-Regulating β-Catenin. Cell Physiol Biochem. 2018;51(6):2794–2813.
   PubMedGoogle Scholar